C1537720||MicroRNA-22
C0085196||6-Hydroxydopamine
C0007634||Cell
C0684309||Model
C0030567||Parkinson's Disease
C0017263||Regulation
C0017337||Gene
C1425224||transient receptor potential melastatin 7
C0030567||Parkinson's disease
C0030567||Parkinson's disease
C0205391||prevalent
C0524851||neurodegenerative disorder
C0087111||treatment
C1512035||dopaminergic neurons
C0025462||midbrain
C1101610||microRNAs
C1101610||microRNAs
C1514248||regulate post-transcriptional
C0017262||gene expression
C0027765||neuronal disease
C2603343||study
C1537720||miR-22
C0085262||PC12 pheochromocytoma cells
C0085196||6-hydroxydopamine
C0085196||6-OHDA
C0030567||Parkinson's disease
C0599161||RT-PCR
C0017262||expression
C1537720||miR-22
C0013081||downregulated
C0085196||6-OHDA
C0085262||PC12 cells
C0017262||overexpression
C1537720||miR-22
C0007620||survival
C0596290||proliferation
C0085196||6-OHDA
C0085262||PC12 cells
C1537720||miR-22
C0085262||PC12 cells
C1537720||miR-22 mimics
C0085196||6-OHDA
C1533734||administration
C0162772||ROS
C1148560||production
C0041904||upregulation
C0013081||downregulation
C1150132||caspase-3 activity
C0024075||luciferase
C2717977||assay
C1425224||transient receptor potential melastatin 7
C1425224||transient receptor potential melastatin 7
C0017337||gene
C1537720||miR-22
C1537720||miR-22
C0017262||overexpression
C0013081||downregulated
C1425224||transient receptor potential melastatin 7
C0936012||analysis
C1537720||miR-22
C0085196||6-OHDA
C0085262||PC12
C0007620||cell survival
C0596290||proliferation
C1425224||transient receptor potential melastatin 7
C2603343||study
C1537720||miR-22
C0017262||overexpression
C0085196||6-OHDA
C0085262||PC12
C0007595||cell growth
C0162638||apoptosis
C1425224||transient receptor potential melastatin 7